Konstantinos Venetis (@konvenetis) 's Twitter Profile
Konstantinos Venetis

@konvenetis

Postdoc Fellow at the Division of Pathology of the European Institute of Oncology

ID: 1335632643954774021

calendar_today06-12-2020 17:10:41

126 Tweet

92 Followers

117 Following

Konstantinos Venetis (@konvenetis) 's Twitter Profile Photo

🩸🧬The why and how of #LiquidBiopsy applications through #ctDNA testing in #BreastCancer are summarized and discussed in our new paper published in The Journal of Liquid Biopsy!sciencedirect.com/science/articl… @NicolaFuscoMD Umberto Malapelle International Society of Liquid Biopsy IEO Università degli Studi di Milano

🩸🧬The why and how of #LiquidBiopsy applications through #ctDNA testing in #BreastCancer are summarized and discussed in our new paper published in The Journal of Liquid Biopsy!sciencedirect.com/science/articl…
@NicolaFuscoMD
<a href="/UmbertoMalapel1/">Umberto Malapelle</a> <a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a> 
<a href="/IEOufficiale/">IEO</a> <a href="/LaStatale/">Università degli Studi di Milano</a>
Konstantinos Venetis (@konvenetis) 's Twitter Profile Photo

#ISLB23 Day 2: Extremely interesting data presented by Ana Vivancos on the use breast milk as a #LiquidBiopsy sample for the early diagnosis of pregnancy-associated breast cancer #PABC 👏🏻🩸 Christian Rolfo Umberto Malapelle M JOSE SERRANO Lab (LB&Cancer Interception group) @NicolaFuscoMD International Society of Liquid Biopsy

#ISLB23 Day 2: Extremely interesting data presented by Ana Vivancos on the use breast milk as a #LiquidBiopsy sample for the early diagnosis of pregnancy-associated breast cancer #PABC 👏🏻🩸
<a href="/ChristianRolfo/">Christian Rolfo</a> <a href="/UmbertoMalapel1/">Umberto Malapelle</a> <a href="/MJOSESERRANO19/">M JOSE SERRANO Lab (LB&Cancer Interception group)</a> @NicolaFuscoMD
<a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a>
Konstantinos Venetis (@konvenetis) 's Twitter Profile Photo

Excellent session on the main pillars that drive Precision Diagnostics with #LiquidBiopsy and a comprehensive overview of the 4oncommunity platform! Congrats @NicolaFuscoMD Umberto Malapelle [email protected] and Matteo Fassan #ISLB23 International Society of Liquid Biopsy

Excellent session on the main pillars that drive Precision Diagnostics with #LiquidBiopsy and a comprehensive overview of the <a href="/4oncommunity/">4oncommunity</a> platform!
Congrats @NicolaFuscoMD <a href="/UmbertoMalapel1/">Umberto Malapelle</a> <a href="/FabioPagni1/">fabio.pagni@unimib.it</a> and Matteo Fassan

#ISLB23
<a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a>
4oncommunity (@4oncommunity) 's Twitter Profile Photo

We are proud to announce the birth of 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, the 4Oncommunity's #Virtual Lab that allows access to exclusive and dynamic in-depth content to keep you up-to-date and improve your skills. Explore the virtual space 4oncommunity.com/en/virtual-lab…

Konstantinos Venetis (@konvenetis) 's Twitter Profile Photo

This clinical case presented by @NicolaFuscoMD at #ISLB23 confirms the great potential of ctDNA testing in providing clinically relevant information encouraging the integration of #LiquidBiopsy with tissue testing in #BreastCancer Umberto Malapelle Christian Rolfo International Society of Liquid Biopsy

This clinical case presented by @NicolaFuscoMD at #ISLB23 confirms the great potential of ctDNA testing in providing clinically relevant information encouraging the integration of #LiquidBiopsy with tissue testing in #BreastCancer
<a href="/UmbertoMalapel1/">Umberto Malapelle</a> <a href="/ChristianRolfo/">Christian Rolfo</a> <a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a>
Umberto Malapelle (@umbertomalapel1) 's Twitter Profile Photo

#ISLB23 ends and we are really greatful to all the 400 collegues joined us in Madrid from 34 different countries and to all the faculty memebers! International Society of Liquid Biopsy family wish you a safe travel to home! See you the next year in Chicago!! Christian Rolfo David Gandara ELO

#ISLB23 ends and we are really greatful to all the 400 collegues joined us in Madrid from 34 different countries and to all the faculty memebers! <a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a> family wish you a safe travel to home! See you the next year in Chicago!! <a href="/ChristianRolfo/">Christian Rolfo</a> <a href="/drgandara/">David Gandara</a> <a href="/ElJanLe/">ELO</a>
Carmen Criscitiello (@carmencriscit) 's Twitter Profile Photo

🔬 New insights at #ESMOBreast24! A study on ESR1 mutations in HR+/HER2- MBC post-CDK4/6i highlights significant findings on patient outcomes and clinical features. Critical for enhancing treatment strategies! #bcsm #ESMOAmbassadors 💊 🧬ESMO - Eur. Oncology Antonio Marra @NicolaFuscoMD

🔬 New insights at #ESMOBreast24! A study on ESR1 mutations in HR+/HER2- MBC post-CDK4/6i highlights significant findings on patient outcomes and clinical features. Critical for enhancing treatment strategies! #bcsm #ESMOAmbassadors 💊 🧬<a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/antoniomarraMD/">Antonio Marra</a> @NicolaFuscoMD
International Society of Liquid Biopsy (@isliquidbiopsy) 's Twitter Profile Photo

🎉 Celebrating the 20th Anniversary of the first publication on Circulating Tumor Cells! 📖🔬 Stay tuned for photos and highlights as we look back on two decades of groundbreaking research and progress. #CTC20Years #CancerResearch #MedicalMilestone

🎉 Celebrating the 20th Anniversary of the first publication on Circulating Tumor Cells! 📖🔬 Stay tuned for photos and highlights as we look back on two decades of groundbreaking research and progress. #CTC20Years #CancerResearch #MedicalMilestone
Erick Saldanha, MD (@esaldanhamd) 's Twitter Profile Photo

🤩🔥Delighted to share our editorial with this stellar team, talking about the role of liquid biopsy in the sustained progression of precision oncology. Also highlighted in the presentation by our committee chair Carolina Reduzzi today in the International Society of Liquid Biopsy 20th year anniversary

🤩🔥Delighted to share our editorial with this stellar team, talking about the role of liquid biopsy in the sustained progression of precision oncology. Also highlighted in the presentation by our committee chair <a href="/ReduzziCarol/">Carolina Reduzzi</a> today in the <a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a>  20th year anniversary
Ana Ortega Franco (@a_ortegafranco) 's Twitter Profile Photo

Very proud to work with Carolina Reduzzi Eleonora Nicolò & International Society of Liquid Biopsy young group in this review on 20years of CTCs discovery #liquidbiopsy 🩺 Clinical significance 📊 Multi-analyte analysis ⏩ Future perspectives & clinical trials 💊 👇 sciencedirect.com/science/articl…

Very proud to work with <a href="/ReduzziCarol/">Carolina Reduzzi</a> <a href="/eleonora_nicolo/">Eleonora Nicolò</a> &amp;  <a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a> young group in this review on 20years of CTCs discovery 
#liquidbiopsy 
 
🩺 Clinical significance
📊 Multi-analyte analysis 
⏩ Future perspectives &amp; clinical trials 💊

👇
sciencedirect.com/science/articl…
OncoAlert (@oncoalert) 's Twitter Profile Photo

Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors just out on Critical Reviews in Oncology Hematology (CROH) Circulating tumor cells (CTCs) 🔬have emerged as significant prognostic biomarkers across various solid tumors, with recent studies

Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors just out on <a href="/CHematology/">Critical Reviews in Oncology Hematology (CROH)</a>

Circulating tumor cells (CTCs) 🔬have emerged as significant prognostic biomarkers across various solid tumors, with recent studies
Carolina Reduzzi (@reduzzicarol) 's Twitter Profile Photo

Today we launched the "ISLB Global Survey: Oncologist Attitudes and Practices on Liquid Biopsy" to collect worldwide data on the use of liquid biopsy in clinical practice! Help us sharing the survey with all the oncologists you know :) docs.google.com/forms/d/e/1FAI…

Today we launched the "ISLB Global Survey: Oncologist Attitudes and Practices on Liquid Biopsy" to collect worldwide data on the use of liquid biopsy in clinical practice!
Help us sharing the survey with all the oncologists you know :)
docs.google.com/forms/d/e/1FAI…
Konstantinos Venetis (@konvenetis) 's Twitter Profile Photo

🩸Wrapping up an inspiring three days at the 6th Annual Congress of the International Society of Liquid Biopsy! A big thank you to the organizers for an exceptional event. Already looking forward to the next one! Umberto Malapelle Christian Rolfo Carolina Reduzzi @nicolafuscomd

🩸Wrapping up an inspiring three days at the 6th Annual Congress of the <a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a>!

A big thank you to the organizers for an exceptional event. Already looking forward to the next one!
<a href="/UmbertoMalapel1/">Umberto Malapelle</a>
<a href="/ChristianRolfo/">Christian Rolfo</a> <a href="/ReduzziCarol/">Carolina Reduzzi</a> @nicolafuscomd
OncoAlert (@oncoalert) 's Twitter Profile Photo

Survey Participation Request on Behalf of International Society of Liquid Biopsy & OncoAlert Oncologist Attitudes and Practices on Liquid Biopsy 👉 buff.ly/4gn5GON This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care.

Survey Participation Request on Behalf of <a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a> &amp; <a href="/OncoAlert/">OncoAlert</a>
Oncologist Attitudes and Practices on Liquid Biopsy 
👉  buff.ly/4gn5GON

This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care.
Carmen Criscitiello (@carmencriscit) 's Twitter Profile Photo

📢 Just out in Cancer Treatment Reviews! We explore a key challenge in HR+/HER2– BC: resistance to CDK4/6i. 💡 Why it happens 🔄 How to overcome it with combos 🚀 What’s next Proud of the great collaborative effort behind this work. 📖 doi.org/10.1016/j.ctrv…

📢 Just out in Cancer Treatment Reviews!
We explore a key challenge in HR+/HER2– BC: resistance to CDK4/6i.
💡 Why it happens
🔄 How to overcome it with combos
🚀 What’s next
Proud of the great collaborative effort behind this work.
📖 doi.org/10.1016/j.ctrv…